Search

Your search keyword '"Mark A. Rubin"' showing total 492 results

Search Constraints

Start Over You searched for: Author "Mark A. Rubin" Remove constraint Author: "Mark A. Rubin" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
492 results on '"Mark A. Rubin"'

Search Results

1. Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course

2. Alterations in homologous recombination repair genes in prostate cancer brain metastases

3. Comparative pathology of dog and human prostate cancer

4. Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression

5. G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer

6. Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia

7. Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer

8. Patient-derived xenografts and organoids model therapy response in prostate cancer

9. Common germline-somatic variant interactions in advanced urothelial cancer

10. Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

11. Fusions involving BCOR and CREBBP are rare events in infiltrating glioma

12. Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes

13. Pathway and network analysis of more than 2500 whole cancer genomes

14. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci

15. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes

16. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling

17. NSD2 is a conserved driver of metastatic prostate cancer progression

18. Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses

19. Patient derived organoids to model rare prostate cancer phenotypes

20. Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics

21. Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network

22. Inherited determinants of early recurrent somatic mutations in prostate cancer

23. A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors

24. Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis

25. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

26. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

27. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

28. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

29. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

30. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

31. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

32. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

33. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

34. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

35. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

36. The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer

38. <scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma

39. Supplementary Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations

40. Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations

41. DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations

42. Table S2 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

43. Index of Supplementary Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework

44. Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework

45. Detailed Materials and Methods from OncoLoop: A Network-Based Precision Cancer Medicine Framework

46. Supplementary Figures S1-S11 from OncoLoop: A Network-Based Precision Cancer Medicine Framework

47. Supplementary Data Index from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation

48. Supplementary Table 3 from Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

49. Supplementary Figure S1 - S8 from The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

50. Data from Next Generation Sequencing of Prostate Cancer from a Patient Identifies a Deficiency of Methylthioadenosine Phosphorylase, an Exploitable Tumor Target

Catalog

Books, media, physical & digital resources